Arvind Mathur

3.6k citations

167 papers · 3.0k · h-index 29

Impact in

Organic Chemistry top 1%
- Catalytic C–H Functionalization Methods
- Radical Photochemical Reactions
- Sulfur-Based Synthesis Techniques
- Synthesis and Catalytic Reactions
- Synthesis and Biological Evaluation
Pharmaceutical Science top 2%
- Fluorine in Organic Chemistry

Papers in

Organic Chemistry 66
- Catalytic C–H Functionalization Methods 13
- Radical Photochemical Reactions 11
- Synthesis and Biological Evaluation 10
Molecular Biology 86
- Chemical Synthesis and Analysis 22
- Sphingolipid Metabolism and Signaling 10

Co-authors: Nicholas A. Meanwell (9 shared papers)Arun Kumar Gupta (6 shared papers)James Kempson (21 shared papers)T. G. Murali Dhar (13 shared papers)Martins S. Oderinde (9 shared papers)Anuradha Gupta (24 shared papers)Antonio Ramı́rez (4 shared papers)Joseph M. Pawluczyk (7 shared papers)
Journals: Journal of Medicinal Chemistry (43 papers)ACS Medicinal Chemistry Letters (19 papers)Bioorganic & Medicinal Chemistry Letters (19 papers)Organic Process Research & Development (16 papers)Journal of Chromatography A (8 papers)
Partner nations: United States India Germany

In The Last Decade

Arvind Mathur

159 papers receiving 2.8k citations

Peers

Countries citing papers authored by Arvind Mathur

Since Specialization

Citations

This map shows the geographic impact of Arvind Mathur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Mathur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Mathur more than expected).

Fields of papers citing papers by Arvind Mathur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvind Mathur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Mathur. The network helps show where Arvind Mathur may publish in the future.

Co-authors

The 25 scholars most cited alongside Arvind Mathur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arvind Mathur Line = papers co-authored together Arvind Mathur links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Synthesis of Cyclobutane-Fused Tetracyclic Scaffolds via Visible-Light Photocatalysis for Building Molecular Complexity Journal of the American Chemical Society ·Martins S. Oderinde, Edna Mao, Antonio Ramı́rez, Joseph M. Pawluczyk, Christine Jorge, Lyndon A. M. Cornelius, James Kempson, Muthalagu Vetrichelvan	2020	132
2	Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton’s Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers Journal of Medicinal Chemistry ·Scott H. Watterson, George V. De Lucca, Qing Wen Shi, Charles M. Langevine, Qingjie Liu, Douglas G. Batt, Myra Beaudoin Bertrand, Hua Gong	2016	130
3	Utilization of C(sp3)‐Carboxylic Acids and Their Redox‐Active Esters in Decarboxylative Carbon−Carbon Bond Formation Advanced Synthesis & Catalysis ·Sukhen Karmakar, Arundutt Silamkoti, Nicholas A. Meanwell, Arvind Mathur, Arun Kumar Gupta	2021	130
4	Discovery and Preclinical Studies of (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor Journal of Medicinal Chemistry ·Rajeev S. Bhide, Zhen‐Wei Cai, Yong‐Zheng Zhang, Ligang Qian, Donna D. Wei, Stephanie A. Lodise Barbosa, Louis J. Lombardo, R. M. Borzilleri	2006	115
5	Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton’s Tyrosine Kinase (BTK) Journal of Medicinal Chemistry ·Scott H. Watterson, Qingjie Liu, Myra Beaudoin Bertrand, Douglas G. Batt, Ling Li, Mark A. Pattoli, Stacey Skala, Lihong Cheng	2019	96
6	Discovery of a 2,4-Disubstituted Pyrrolo[1,2-f][1,2,4]triazine Inhibitor (BMS-754807) of Insulin-like Growth Factor Receptor (IGF-1R) Kinase in Clinical Development Journal of Medicinal Chemistry ·Mark D. Wittman, Joan M. Carboni, Yang Zheng, Francis Y. Lee, Melissa Antman, Ricardo M. Attar, Praveen V. Balimane, ChiehYing Chang	2009	87
7	Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors ACS Medicinal Chemistry Letters ·Ashvinikumar V. Gavai, Claude A. Quesnelle, Derek J. Norris, Wen-Ching Han, Patrice Gill, Weifang Shan, Aaron J. Balog, Ke Chen	2015	80
8	Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy Journal of Medicinal Chemistry ·Andrew K. Dilger, Kumar B. Pabbisetty, James R. Corte, Indawati De Lucca, Tianan Fang, Wu Yang, Donald J. P. Pinto, Yufeng Wang	2021	78
9	Photocatalytic Dearomative Intermolecular [2 + 2] Cycloaddition of Heterocycles for Building Molecular Complexity The Journal of Organic Chemistry ·Martins S. Oderinde, Antonio Ramı́rez, T. G. Murali Dhar, Lyndon A. M. Cornelius, Christine Jorge, Darpandeep Aulakh, Bhupinder Kaur Sandhu, Joseph M. Pawluczyk	2020	74
10	Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of N-[[2‘-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1‘-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), A Highly Potent and Orally Active ETA Selective Antagonist Journal of Medicinal Chemistry ·Natesan Murugesan, Zhengxiang Gu, Steven H. Spergel, MARIAN G. YOUNG, Ping Chen, Arvind Mathur, Leslie W. Leith, Mark A. Hermsmeier	2002	60
11	Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors Bioorganic & Medicinal Chemistry Letters ·James C. Sutton, Scott A. Bolton, Malcolm E. Davis, Karen S. Hartl, Bruce L. Jacobson, Arvind Mathur, Martin L. Ogletree, William A. Slusarchyk	2004	57
12	Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse Agonists ACS Medicinal Chemistry Letters ·James J.‐W. Duan, Zhonghui Lu, Bin Jiang, Sylwia Stachura, Carolyn A. Weigelt, John S. Sack, Javed Khan, Max Ruzanov	2019	50
13	Small Molecule Reversible Inhibitors of Bruton’s Tyrosine Kinase (BTK): Structure–Activity Relationships Leading to the Identification of 7-(2-Hydroxypropan-2-yl)-4-[2-methyl-3-(4-oxo-3,4-dihydroquinazolin-3-yl)phenyl]-9H-carbazole-1-carboxamide (BMS-935177) Journal of Medicinal Chemistry ·George V. De Lucca, Qing Wen Shi, Qingjie Liu, Douglas G. Batt, Myra Beaudoin Bertrand, Rick Rampulla, Arvind Mathur, Lorell Discenza	2016	47
14	Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial European Heart Journal ·Aldo Pietro Maggioni, Sally Greene, Gregg Fonarow, Michael C Böhm, Faiez M. Zannad, Scott David Solomon, E. F. Lewis, Fabio Baschiera	2013	47
15	Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212) Journal of Medicinal Chemistry ·Donald J. P. Pinto, Michael J. Orwat, Leon M. Smith, Mimi L. C. Quan, Patrick Y. S. Lam, Karen A. Rossi, Atsu Apedo, Jeffrey M. Bozarth	2017	45
16	Acridone-Based Inhibitors of Inosine 5‘-Monophosphate Dehydrogenase: Discovery and SAR Leading to the Identification of N-(2-(6-(4-Ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419) Journal of Medicinal Chemistry ·Scott H. Watterson, Ping Chen, Yufen Zhao, Henry H. Gu, T. G. Murali Dhar, Zili Xiao, Shelley K. Ballentine, Zhongqi Shen	2007	45
17	Discovery and Development of 5-[(5S,9R)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 Journal of Medicinal Chemistry ·Dominique Potin, Michèle Launay, Francoise Monatlik, Patrice Malabre, Maud Fabreguettes, Andre Fouquet, Magali Maillet, Eric Nicolaï	2006	44
18	Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist ACS Medicinal Chemistry Letters ·Robert J. Cherney, Lyndon A. M. Cornelius, Anurag Srivastava, Carolyn A. Weigelt, David Marcoux, James J.‐W. Duan, Qing Wen Shi, Douglas G. Batt	2020	39
19	Biphenylsulfonamide Endothelin Antagonists: Structure−Activity Relationships of a Series of Mono- and Disubstituted Analogues and Pharmacology of the Orally Active Endothelin Antagonist 2‘-Amino- N - (3,4-dimethyl-5-isoxazolyl)-4‘-(2-methylpropyl)[1,1‘-biphenyl]-2-sulfonamide (BMS-187308) Journal of Medicinal Chemistry ·Natesan Murugesan, Zhengxiang Gu, Philip D. Stein, Sharon N. Bisaha, Steven H. Spergel, R.N. Girotra, Ving G. Lee, John Lloyd	1998	38
20	Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design Journal of Medicinal Chemistry ·Ashvinikumar V. Gavai, Derek J. Norris, George V. Delucca, David R. Tortolani, John S. Tokarski, Dharmpal S. Dodd, Daniel O’Malley, Yufen Zhao	2021	37

About Arvind Mathur

Arvind Mathur is a scholar working on Organic Chemistry, Molecular Biology, Spectroscopy, Oncology and Immunology, having authored 167 papers that have together received 3.0k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (22 papers), Analytical Chemistry and Chromatography (17 papers), Catalytic C–H Functionalization Methods (13 papers), Radical Photochemical Reactions (11 papers), Sphingolipid Metabolism and Signaling (10 papers), Synthesis and Biological Evaluation (10 papers), HIV/AIDS drug development and treatment (9 papers) and Cytokine Signaling Pathways and Interactions (8 papers). The work is most often cited by research in Organic Chemistry (1.4k citations), Pharmaceutical Science (194 citations), Genetics (244 citations), Molecular Biology (1.0k citations) and Oncology (352 citations). Arvind Mathur has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Nicholas A. Meanwell, Arun Kumar Gupta, James Kempson, T. G. Murali Dhar, Martins S. Oderinde, Anuradha Gupta, Antonio Ramı́rez, Joseph M. Pawluczyk, Christine Jorge and Lyndon A. M. Cornelius. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry Letters, Organic Process Research & Development and Journal of Chromatography A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Arvind Mathur

Impact in

Papers in i

In The Last Decade

Arvind Mathur

Peers

Countries citing papers authored by Arvind Mathur

Fields of papers citing papers by Arvind Mathur

All Works

About Arvind Mathur

Explore authors with similar magnitude of impact

Papers in